标题
Current Prevention of COVID-19: Natural Products and Herbal Medicine
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-10-16
DOI
10.3389/fphar.2020.588508
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools
- (2020) Qi Kong et al. BIOMEDICINE & PHARMACOTHERAPY
- A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
- (2020) Yong-Zhen Zhang et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
- (2020) Toshio Hirano et al. IMMUNITY
- Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants
- (2020) Gideon A. Gyebi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Natural products may interfere with SARS-CoV-2 attachment to the host cell
- (2020) Abdo A. Elfiky JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
- (2020) Vipul Kumar et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Convalescent serum lines up as first-choice treatment for coronavirus
- (2020) Cormac Sheridan NATURE BIOTECHNOLOGY
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- (2020) Yan Wu et al. SCIENCE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- Race to find COVID-19 treatments accelerates
- (2020) Kai Kupferschmidt et al. SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- Traditional Chinese Medicine treatment of COVID-19
- (2020) Jia Xu et al. Complementary Therapies in Clinical Practice
- Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
- (2020) Muhammad Tahir ul Qamar et al. Journal of Pharmaceutical Analysis
- Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
- (2020) Julia del Amo et al. ANNALS OF INTERNAL MEDICINE
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
- (2020) Christoph Kreer et al. CELL
- SARS‐CoV‐2 and SARS‐CoV: Virtual screening of potential inhibitors targeting RNA‐dependent RNA polymerase activity (NSP12)
- (2020) Zijing Ruan et al. JOURNAL OF MEDICAL VIROLOGY
- Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
- (2020) Qiangzhe Zhang et al. NANO LETTERS
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
- (2020) Seth J. Zost et al. NATURE MEDICINE
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
- (2020) Jiangdong Huo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good
- (2020) Paul E. Gray et al. PHARMACOLOGICAL RESEARCH
- Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway
- (2020) Qinhai Ma et al. PHARMACOLOGICAL RESEARCH
- Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19)
- (2020) Yu-Feng Huang et al. PHARMACOLOGICAL RESEARCH
- Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
- (2020) Ruocong Yang et al. PHARMACOLOGICAL RESEARCH
- The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
- (2020) Dan Zhang et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
- (2020) Johanna Hansen et al. SCIENCE
- Effects of four bamboo derived flavonoids on advanced glycation end products formation in vitro
- (2020) Man-yu Lan et al. Journal of Functional Foods
- Bioactive natural compounds against human coronaviruses: a review and perspective
- (2020) Yanfang Xian et al. Acta Pharmaceutica Sinica B
- The Significance of Natural Product Derivatives and Traditional Medicine for COVID-19
- (2020) Dongdong Wang et al. Processes
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses
- (2018) Christin Müller et al. ANTIVIRAL RESEARCH
- The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
- (2018) Daniel Todt et al. ANTIVIRAL RESEARCH
- Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms
- (2018) Wei Wang et al. CARCINOGENESIS
- Virucidal, antiviral and immunomodulatory activities of β-escin and Aesculus hippocastanum extract
- (2018) Flavia M. Michelini et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein
- (2018) Ji Yeun Kim et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
- (2017) Yuan Yuan et al. Nature Communications
- A Comprehensive Strategy to Evaluate Compatible Stability of Chinese Medicine Injection and Infusion Solutions Based on Chemical Analysis and Bioactivity Assay
- (2017) Jian-Ping Li et al. Frontiers in Pharmacology
- Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin
- (2016) Jean K. Millet et al. ANTIVIRAL RESEARCH
- An analysis of FDA-approved drugs: natural products and their derivatives
- (2016) Eric Patridge et al. DRUG DISCOVERY TODAY
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
- (2014) Jean Kaoru Millet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13
- (2012) Mi-Sun Yu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infections
- (2011) B. Glatthaar-Saalmüller et al. PHYTOMEDICINE
- The biological potential of flavones
- (2010) Alok Kumar Verma et al. NATURAL PRODUCT REPORTS
- Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses
- (2010) Martin Michaelis et al. PHYTOMEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now